July, 2015 | The Wall Street Analyzer

Latest News

[ September 21, 2021 ] Golden Independence Intersects 1.71 g/t Gold and 6.0 g/t Silver over 70 Feet at Independence Project News Feed
[ September 14, 2021 ] Successful Trenching Programme in the Kobada Est Target Confirms Similar Structural Mineralization to Kobada Main Shear News Feed
[ September 9, 2021 ] Goldshore Resources Receives Initial Magnetics Images from Geotech VTEM System Survey on the Moss Lake Gold Project News Feed
[ September 7, 2021 ] Citius Pharmaceuticals Acquires Dr. Reddy’s Laboratories’ License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications News Feed
[ September 2, 2021 ] African Gold Group Delivers a 44% Increase in Measured and Indicated Mineral Resource for the Kobada Gold Project to 1.71 Million Ounces News Feed
[ August 27, 2021 ] Pro-Dex, Inc. Announces Fiscal 2021 Fourth Quarter and Full-Year Results News Feed
[ August 27, 2021 ] BluMetric Announces Strong Financial Results for Q3 2021 News Feed

Farmland Partners Inc (NYSE:FPI) CEO Interview

July 31, 2015 The Wall Street Analyzer Comments Off

Interview with CEO Paul Pittman […]

DelMar Pharmaceuticals (OTCQX:DMPI) CEO Interview

July 30, 2015 The Wall Street Analyzer Comments Off

Interview with Jeff Bacha, CEO […]

OCI Partners LP Schedules 2015 Second Quarter Results Conference Call

July 30, 2015 The Wall Street Analyzer Comments Off

NYSE:OCIP […]

Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

July 30, 2015 The Wall Street Analyzer Comments Off

Up to $9.5 Million in Debt Financing and $12 Million in Equity Financing.

Company to Advance its Immuno-Dermatology and Inflammatory Bowel Disease Product Candidates
Lead Compound Bertilimumab, First-in-Class Autoimmune Therapy, a Priority
[…]

Viveve Medical, Inc. (OTCQB:VIVMF) CEO Interview

July 28, 2015 The Wall Street Analyzer Comments Off

Interview with CEO Patricia Scheller […]

Karnalyte Resources (TSX:KRN) CEO Interview

July 22, 2015 The Wall Street Analyzer Comments Off

Interview with Robin Phinney, CEO […]

Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

July 20, 2015 The Wall Street Analyzer Comments Off

NASDAQ:EDUC […]

Pieris Pharma (NASDAQ:PIRS) CEO Interview

July 20, 2015 The Wall Street Analyzer Comments Off

Interview with Steve Yoder, CEO […]

Immune Pharmaceuticals Joins The Russell Microcap Index

July 20, 2015 The Wall Street Analyzer Comments Off

NASDAQ:IMNP […]

Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells

July 20, 2015 The Wall Street Analyzer Comments Off

Will Also Participate in Additional Wattenberg Well […]

Month: July 2015

Farmland Partners Inc (NYSE:FPI) CEO Interview

DelMar Pharmaceuticals (OTCQX:DMPI) CEO Interview

OCI Partners LP Schedules 2015 Second Quarter Results Conference Call

Immune Pharmaceuticals Secures Funding of up to $21.5 Million from Institutional Investors

Viveve Medical, Inc. (OTCQB:VIVMF) CEO Interview

Karnalyte Resources (TSX:KRN) CEO Interview

Educational Development Corporation Announces Results for First Quarter of Fiscal Year 2016

Pieris Pharma (NASDAQ:PIRS) CEO Interview

Immune Pharmaceuticals Joins The Russell Microcap Index

Pacific Energy Development Announces Commencement of Drilling This Week on Seven New Wattenberg Wells

Co-Diagnostics (NASDAQ: CODX) is Well-positioned with 3 Key Verticals

Client Testimonials: